{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:38:49Z","timestamp":1792633129951,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fundaci\u00f3n Instituto Carlos III","award":["PI20\/01768"],"award-info":[{"award-number":["PI20\/01768"]}]},{"name":"Ministerio de Asuntos Econ\u00f3micos y Transformaci\u00f3n Digital","award":["MIA.2021.M02.0005"],"award-info":[{"award-number":["MIA.2021.M02.0005"]}]},{"name":"European Commission","award":["101057263"],"award-info":[{"award-number":["101057263"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"DOI":"10.1186\/s12877-026-08023-3","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T11:35:21Z","timestamp":1784979321000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vascular risk factors after stroke in the older people: a population-based study"],"prefix":"10.1186","volume":"26","author":[{"given":"Maider","family":"Iza Achutegui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Olive-Gadea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Colangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00e1n","family":"Muchada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Rodrigo-Gisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Garc\u00eda-Tornel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Requena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Rodriguez-Villatoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Juega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rodr\u00edguez-Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Pagola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ribo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rubiera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"8023_CR1","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/0140-6736(92)91658-u","volume":"339","author":"R Bonita","year":"1992","unstructured":"Bonita R. Epidemiology of stroke. Lancet. 1992;339:342\u20134. https:\/\/doi.org\/10.1016\/0140-6736(92)91658-u.","journal-title":"Lancet"},{"key":"8023_CR2","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1160\/TH15-07-0577","volume":"115","author":"Y Guo","year":"2016","unstructured":"Guo Y, Wang H, Tian Y, Wang Y, Lip GY. Multiple risk factors and ischaemic stroke in the elderly Asian population with and without atrial fibrillation. An analysis of 425,600 Chinese individuals without prior stroke. Thromb Haemost. 2016;115:184\u201392. https:\/\/doi.org\/10.1160\/TH15-07-0577.","journal-title":"Thromb Haemost"},{"issue":"1, Cerebrovascu","key":"8023_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1212\/CON.0000000000000416","volume":"23","author":"A Guzik","year":"2017","unstructured":"Guzik A, Bushnell C. Stroke Epidemiology and Risk Factor Management. Continuum (Minneap Minn). 2017;23(1, Cerebrovascular Disease):15\u201339. https:\/\/doi.org\/10.1212\/CON.0000000000000416.","journal-title":"Continuum (Minneap Minn)"},{"issue":"2","key":"8023_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(13)70255-2","volume":"13","author":"GJ Hankey","year":"2014","unstructured":"Hankey GJ. Secondary stroke prevention. Lancet Neurol. 2014;13(2):178\u201394. https:\/\/doi.org\/10.1016\/S1474-4422(13)70255-2.","journal-title":"Lancet Neurol"},{"issue":"7","key":"8023_CR5","doi-asserted-by":"publisher","first-page":"CD007858","DOI":"10.1002\/14651858.CD007858","volume":"7","author":"TP Zonneveld","year":"2018","unstructured":"Zonneveld TP, Richard E, Vergouwen MD, Nederkoorn PJ, de Haan R, Roos YB, et al. Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack. Cochrane Database Syst Rev. 2018;7(7):CD007858. https:\/\/doi.org\/10.1002\/14651858.CD007858.","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"8023_CR6","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1161\/STROKEAHA.107.493106","volume":"38","author":"P Amarenco","year":"2007","unstructured":"Amarenco P, Goldstein LB, Szarek M, Sillesen H, Rudolph AE, Callahan A 3, et al. Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2007;38(12):3198\u2013204. https:\/\/doi.org\/10.1161\/STROKEAHA.107.493106.","journal-title":"Stroke"},{"issue":"4","key":"8023_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3109\/07853891003796752","volume":"42","author":"CY Zhang","year":"2010","unstructured":"Zhang CY, Sun AJ, Zhang SN, Wu CN, Fu MQ, Xia G, et al. Effects of intensive glucose control on incidence of cardiovascular events in patients with type 2 diabetes: a meta-analysis. Ann Med. 2010;42(4):305\u201315. https:\/\/doi.org\/10.3109\/07853891003796752.","journal-title":"Ann Med"},{"issue":"7258","key":"8023_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","volume":"321","author":"IM Stratton","year":"2000","unstructured":"Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405\u201312. https:\/\/doi.org\/10.1136\/bmj.321.7258.405.","journal-title":"BMJ"},{"issue":"3","key":"8023_CR9","doi-asserted-by":"publisher","first-page":"I","DOI":"10.1177\/23969873221100032","volume":"7","author":"J Dawson","year":"2022","unstructured":"Dawson J, B\u00e9jot Y, Christensen LM, De Marchis GM, Dichgans M, Hagberg G, et al. European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack. Eur Stroke J. 2022;7(3):I\u2013II. https:\/\/doi.org\/10.1177\/23969873221100032.","journal-title":"Eur Stroke J"},{"issue":"7","key":"8023_CR10","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1161\/STROKEAHA.118.024497","volume":"50","author":"JP Greving","year":"2019","unstructured":"Greving JP, Diener HC, Reitsma JB, Bath PM, Csiba L. Hacke Wet al. Antiplatelet Therapy After Noncardioembolic Stroke. Stroke. 2019;50(7):1812\u20138. https:\/\/doi.org\/10.1161\/STROKEAHA.118.024497.","journal-title":"Stroke"},{"issue":"3","key":"8023_CR11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/2396987319841187","volume":"4","author":"CJ Klijn","year":"2019","unstructured":"Klijn CJ, Paciaroni M, Berge E, Korompoki E, K\u00f5rv J, Lal A, et al. Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline. Eur Stroke J. 2019;4(3):198\u2013223. https:\/\/doi.org\/10.1177\/2396987319841187.","journal-title":"Eur Stroke J"},{"issue":"4","key":"8023_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/2396987318808719","volume":"3","author":"B Norrving","year":"2018","unstructured":"Norrving B, Barrick J, Davalos A, Dichgans M, Cordonnier C, Guekht A, et al. Action Plan for Stroke in Europe 2018\u20132030. Eur Stroke J. 2018;3(4):309\u201336. https:\/\/doi.org\/10.1177\/2396987318808719.","journal-title":"Eur Stroke J"},{"issue":"6","key":"8023_CR13","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/europace\/euq102","volume":"12","author":"L Fauchier","year":"2010","unstructured":"Fauchier L, Lip GY. Guidelines for antithrombotic therapy in atrial fibrillation: understanding the reasons for non-adherence and moving forwards with simplifying risk stratification for stroke and bleeding. Europace. 2010;12(6):761\u20133. https:\/\/doi.org\/10.1093\/europace\/euq102.","journal-title":"Europace"},{"issue":"47\u201348","key":"8023_CR14","doi-asserted-by":"publisher","first-page":"757","DOI":"10.4414\/smw.2006.11486","volume":"136","author":"BS Zehnder","year":"2006","unstructured":"Zehnder BS, Schaer BA, Jeker U, Cron TA, Osswald S. Atrial fibrillation: estimated excess rate of stroke due to lacking adherence to guidelines. Swiss Med Wkly. 2006;136(47\u201348):757\u201360. https:\/\/doi.org\/10.4414\/smw.2006.11486.","journal-title":"Swiss Med Wkly"},{"issue":"4","key":"8023_CR15","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1161\/STROKEAHA.108.526988","volume":"40","author":"C Van Walraven","year":"2009","unstructured":"Van Walraven C, Hart RG, Connolly S, Austin PC, Mant J, Hobbs FD, et al. Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators. Stroke. 2009;40(4):1410\u20136. https:\/\/doi.org\/10.1161\/STROKEAHA.108.526988.","journal-title":"Stroke"},{"issue":"8","key":"8023_CR16","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1177\/17474930251345295","volume":"20","author":"NR Evans","year":"2025","unstructured":"Evans NR, Pinho J, Beishon L, et al. Frailty and stroke: Global implications for assessment, research, and clinical care-A WSO scientific statement. Int J Stroke. 2025;20(8):905\u201317. https:\/\/doi.org\/10.1177\/17474930251345295.","journal-title":"Int J Stroke"},{"issue":"5","key":"8023_CR17","doi-asserted-by":"publisher","first-page":"100853","DOI":"10.1016\/j.lanhl.2026.100853","volume":"7","author":"TJ Quinn","year":"2026","unstructured":"Quinn TJ, Evans N, Fearon P, Gallacher KI. Stroke in older adults: exploring the intersections of comorbidity, disability, and frailty. Lancet Healthy Longev. 2026;7(5):100853. https:\/\/doi.org\/10.1016\/j.lanhl.2026.100853 . Epub 2026 May 19. PMID: 42155498.","journal-title":"Lancet Healthy Longev"},{"issue":"4","key":"8023_CR18","doi-asserted-by":"publisher","first-page":"e12434","DOI":"10.1111\/jjns.12434","volume":"18","author":"W Srithumsuk","year":"2021","unstructured":"Srithumsuk W, Chaleoykitti S, Jaipong S, Pattayakorn P, Podimuang K. Association between depression and medication adherence in stroke survivor older adults. Jpn J Nurs Sci. 2021;18(4):e12434. https:\/\/doi.org\/10.1111\/jjns.12434 . Epub 2021 Jun 17. PMID: 34137175.","journal-title":"Jpn J Nurs Sci"},{"issue":"1","key":"8023_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/HYPERTENSIONAHA.119.14125","volume":"75","author":"D Clark 3rd","year":"2020","unstructured":"Clark D 3rd, Hall ME, Jones DW. Dilemma of Blood Pressure Management in Older and Younger Adults. Hypertension. 2020;75(1):35\u20137. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.14125 . Epub 2019 Nov 25. PMID: 31760885.","journal-title":"Hypertension"},{"issue":"3","key":"8023_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1161\/HYPERTENSIONAHA.124.24214","volume":"82","author":"L Chen","year":"2025","unstructured":"Chen L, You S, Ee N, Rockwood K, Ward DD, Woodward M, Liu T, Gao Y, Williamson JD, Anderson CS, Harris K, Chen X, Peters R. Impact of Frailty on Antihypertensive Treatment in Older Adults. Hypertension. 2025;82(3):509\u201319. Epub 2025 Jan 14. PMID: 39807596.","journal-title":"Hypertension"},{"key":"8023_CR21","unstructured":"Gynnild MN, Aaker\u00f8y R, Spigset O, Zheng YJ, Liu K, Cheng A et al. W. The Impact of Cognitive Function on the."},{"key":"8023_CR22","doi-asserted-by":"publisher","first-page":"777250","DOI":"10.3389\/fcvm.2021.777250","volume":"8","author":"Effectiveness and Safety of Intensive Blood Pressure Control for Patients With Hypertension","year":"2021","unstructured":"Effectiveness and Safety of Intensive Blood Pressure Control for Patients With Hypertension. A post-hoc Analysis of SPRINT. Front Cardiovasc Med. 2021;8:777250. https:\/\/doi.org\/10.3389\/fcvm.2021.777250.","journal-title":"Front Cardiovasc Med"},{"issue":"7","key":"8023_CR23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1161\/CIRCULATIONAHA.123.064003","volume":"148","author":"Z Wang","year":"2023","unstructured":"Wang Z, Du X, Hua C, Li W, Zhang H, Liu X, et al. The Effect of Frailty on the Efficacy and Safety of Intensive Blood Pressure Control: A Post Hoc Analysis of the SPRINT Trial. Circulation. 2023;148(7):565\u201374. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.064003.","journal-title":"Circulation"},{"issue":"10263","key":"8023_CR24","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/S0140-6736(20)32332-1","volume":"396","author":"B Gencer","year":"2020","unstructured":"Gencer B, Marston NA, Im K, et al. Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials. Lancet. 2020;396(10263):1637\u201343. https:\/\/doi.org\/10.1016\/S0140-6736(20)32332-1.","journal-title":"Lancet"},{"issue":"3","key":"8023_CR25","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1177\/23969873231174942","volume":"8","author":"N Silimon","year":"2023","unstructured":"Silimon N, Drop B, Cl\u00e9nin L, Nedeltchev K, Kahles T, Tarnutzer AA, et al. Ischemic stroke despite antiplatelet therapy: Causes and outcomes. Eur Stroke J. 2023;8(3):692\u2013702. https:\/\/doi.org\/10.1177\/23969873231174942.","journal-title":"Eur Stroke J"},{"issue":"7","key":"8023_CR26","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.amjmed.2009.11.025","volume":"123","author":"IM Ogilvie","year":"2010","unstructured":"Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med. 2010;123(7):638\u2013e6454. https:\/\/doi.org\/10.1016\/j.amjmed.2009.11.025.","journal-title":"Am J Med"},{"issue":"5","key":"8023_CR27","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1093\/ageing\/afv071","volume":"44","author":"A Wolff","year":"2015","unstructured":"Wolff A, Shantsila E, Lip GY, Lane DA. Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice. Age Ageing. 2015;44(5):874\u20138. https:\/\/doi.org\/10.1093\/ageing\/afv071.","journal-title":"Age Ageing"},{"key":"8023_CR28","unstructured":"Enquesta de Salut. de la Poblaci\u00f3 [Internet]. [cited 2024 April 2]. Available at: https:\/\/www.idescat.cat\/pub\/?id=esca"},{"issue":"5","key":"8023_CR29","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1161\/STROKEAHA.123.043691","volume":"55","author":"G Colangelo","year":"2024","unstructured":"Colangelo G, Ribo M, Montiel E, Dominguez D, Oliv\u00e9-Gadea M, Muchada M, et al. PRERISK: A Personalized, Artificial Intelligence-Based and Statistically-Based Stroke Recurrence Predictor for Recurrent Stroke. Stroke. 2024;55(5):1200\u20139. https:\/\/doi.org\/10.1161\/STROKEAHA.123.043691.","journal-title":"Stroke"},{"issue":"7","key":"8023_CR30","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1161\/STROKEAHA.118.024355","volume":"50","author":"M Requena","year":"2019","unstructured":"Requena M, Montiel E, Baladas M, Muchada M, Boned S, L\u00f3pez R, et al. Farmalarm Stroke. 2019;50(7):1819\u201324. https:\/\/doi.org\/10.1161\/STROKEAHA.118.024355.","journal-title":"Farmalarm Stroke"},{"key":"8023_CR31","unstructured":"Harmonics [Internet]. [cited 2024 Apr 2]. Available from: https:\/\/harmonicsproject.eu."},{"issue":"7","key":"8023_CR32","doi-asserted-by":"publisher","first-page":"afae158","DOI":"10.1093\/ageing\/afae158","volume":"53","author":"FC Martin","year":"2024","unstructured":"Martin FC, Quinn TJ, Straus SE, Anand S, van der Velde N, Harwood RH. New horizons in clinical practice guidelines for use with older people. Age Ageing. 2024;53(7):afae158. https:\/\/doi.org\/10.1093\/ageing\/afae158.","journal-title":"Age Ageing"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-026-08023-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-08023-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-08023-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:49:03Z","timestamp":1792630143000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-026-08023-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8023"],"URL":"https:\/\/doi.org\/10.1186\/s12877-026-08023-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7973410\/v1","asserted-by":"object"}]},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study received approval from the local ethical committee (PR(AG)107\/2020). As this is a registry study the medical ethics committee waived the need for obtaining informed consent.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Drs Ribo and Molina are cofounders and hold stock from Nora. Dr Colangelo is the CTO of NoraHealth. Dr Ribo holds stocks from Anaconda Biomed and reported receiving personal fees from AptaTargets, Cerenovus, Medtronic, Methinks, Philips, and Stryker outside the submitted work. Dr Rubiera reported compensation from Bayer for data and safety monitoring services outside the present work. The other authors report no conflicts.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1327"}}